Bleakley Financial Group, LLC Tg Therapeutics, Inc. Transaction History
Bleakley Financial Group, LLC
- $3.32 Trillion
- Q4 2024
A detailed history of Bleakley Financial Group, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 8,140 shares of TGTX stock, worth $269,352. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,140Holding current value
$269,352% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
354Shares Held
90.2MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$509 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$377 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$301 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$119 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$106 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.81B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...